Strauss MH - Search Results

1

Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox.

Strauss MH, Hall AS. Strauss MH, et al. Circulation. 2006 Aug 22;114(8):838-54. doi: 10.1161/CIRCULATIONAHA.105.594986. Circulation. 2006. PMID: 16923768 No abstract available.

2

Renin-angiotensin system and cardiovascular risk.

Strauss MH, Hall A. Strauss MH, et al. Lancet. 2007 Jul 7;370(9581):23-4; author reply 24-5. doi: 10.1016/S0140-6736(07)61034-4. Lancet. 2007. PMID: 17617258 No abstract available.

3

RAS blockers: Does sex matter? Re: Sex differences in the effectiveness of ARB and ACEI in patients with congestive heart failure - A population study: Marie Hudson et al. European Journal of Heart Failure 9 (2007) 602-609.

Strauss MH, Hall A. Strauss MH, et al. Eur J Heart Fail. 2007 Sep;9(9):963-4; author reply 964. doi: 10.1016/j.ejheart.2007.06.010. Epub 2007 Jul 31. Eur J Heart Fail. 2007. PMID: 17669685 Free article. No abstract available.

4

More about the "ARB MI paradox".

Hall AS, Strauss MH. Hall AS, et al. Among authors: strauss mh. Heart. 2007 Sep;93(9):1011-4. doi: 10.1136/hrt.2006.107185. Heart. 2007. PMID: 17699164 Free PMC article.

5

Telmisartan in high-risk patients intolerant of ACE inhibitors.

Hall A, Strauss MH. Hall A, et al. Among authors: strauss mh. Lancet. 2009 Feb 7;373(9662):458; author reply 459. doi: 10.1016/S0140-6736(09)60162-8. Lancet. 2009. PMID: 19200910 No abstract available.

6

Angiotensin receptor blockers should be regarded as first-line drugs for stroke prevention in both primary and secondary prevention settings: no.

Strauss MH, Hall A. Strauss MH, et al. Stroke. 2009 Sep;40(9):3161-2. doi: 10.1161/STROKEAHA.109.559062. Epub 2009 Jul 30. Stroke. 2009. PMID: 19644060 Review. No abstract available.

7

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study.

Strauss MH, Hall AS. Strauss MH, et al. Eur Heart J. 2010 Jan;31(2):261-2; author reply 262. doi: 10.1093/eurheartj/ehp515. Epub 2009 Nov 27. Eur Heart J. 2010. PMID: 19946109 No abstract available.

8

The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.

Strauss MH, Hall AS. Strauss MH, et al. Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):473-82. doi: 10.1016/j.pcad.2015.11.004. Epub 2015 Nov 14. Prog Cardiovasc Dis. 2016. PMID: 26586276 Review.

9

Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.

Strauss MH, Hall AS. Strauss MH, et al. N Engl J Med. 2016 Sep 22;375(12):1191. doi: 10.1056/NEJMc1608916. N Engl J Med. 2016. PMID: 27653574 No abstract available.

10

Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox.

Strauss MH, Hall AS. Strauss MH, et al. Circulation. 2017 May 30;135(22):2088-2090. doi: 10.1161/CIRCULATIONAHA.117.026112. Circulation. 2017. PMID: 28559493 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters